62 related articles for article (PubMed ID: 1316145)
1. Direct gene transfer to the liver with herpes simplex virus type 1 vectors: transient production of physiologically relevant levels of circulating factor IX.
Miyanohara A; Johnson PA; Elam RL; Dai Y; Witztum JL; Verma IM; Friedmann T
New Biol; 1992 Mar; 4(3):238-46. PubMed ID: 1316145
[TBL] [Abstract][Full Text] [Related]
2. Herpes simplex virus type 1 vector mediated gene transfer to muscle.
Huard J; Goins WF; Glorioso JC
Gene Ther; 1995 Aug; 2(6):385-92. PubMed ID: 7584113
[TBL] [Abstract][Full Text] [Related]
3. Efficient in vivo transduction of the neonatal mouse liver with pseudotyped retroviral vectors.
Miyanohara A; Yee JK; Bouic K; LaPorte P; Friedmann T
Gene Ther; 1995 Mar; 2(2):138-42. PubMed ID: 7719930
[TBL] [Abstract][Full Text] [Related]
4. Latency associated promoter transgene expression in the central nervous system after stereotaxic delivery of replication-defective HSV-1-based vectors.
Scarpini CG; May J; Lachmann RH; Preston CM; Dunnett SB; Torres EM; Efstathiou S
Gene Ther; 2001 Jul; 8(14):1057-71. PubMed ID: 11526453
[TBL] [Abstract][Full Text] [Related]
5. beta-Gal enzyme activity driven by the HSV LAT promoter does not correspond to beta-gal RNA levels in mouse trigeminal ganglia.
Huang QS; Valyi-Nagy T; Kesari S; Fraser NW
Gene Ther; 1997 Aug; 4(8):797-807. PubMed ID: 9338008
[TBL] [Abstract][Full Text] [Related]
6. Stabilization of transgene expression by incorporation of E3 region genes into an adenoviral factor IX vector and by transient anti-CD4 treatment of the host.
Poller W; Schneider-Rasp S; Liebert U; Merklein F; Thalheimer P; Haack A; Schwaab R; Schmitt C; Brackmann HH
Gene Ther; 1996 Jun; 3(6):521-30. PubMed ID: 8789802
[TBL] [Abstract][Full Text] [Related]
7. Significantly increased expression of beta-glucuronidase in the central nervous system of mucopolysaccharidosis type VII mice from the latency-associated transcript promoter in a nonpathogenic herpes simplex virus type 1 vector.
Zhu J; Kang W; Wolfe JH; Fraser NW
Mol Ther; 2000 Jul; 2(1):82-94. PubMed ID: 10899831
[TBL] [Abstract][Full Text] [Related]
8. Gene transfer in bovine blastocysts using replication-defective retroviral vectors packaged with Gibbon ape leukemia virus envelopes.
Kim T; Leibfried-Rutledge ML; First NL
Mol Reprod Dev; 1993 Jun; 35(2):105-13. PubMed ID: 8391277
[TBL] [Abstract][Full Text] [Related]
9. Th1-associated immune responses to beta-galactosidase expressed by a replication-defective herpes simplex virus.
Brubaker JO; Thompson CM; Morrison LA; Knipe DM; Siber GR; Finberg RW
J Immunol; 1996 Aug; 157(4):1598-604. PubMed ID: 8759744
[TBL] [Abstract][Full Text] [Related]
10. Several log increase in therapeutic transgene delivery by distinct adeno-associated viral serotype vectors.
Chao H; Liu Y; Rabinowitz J; Li C; Samulski RJ; Walsh CE
Mol Ther; 2000 Dec; 2(6):619-23. PubMed ID: 11124063
[TBL] [Abstract][Full Text] [Related]
11. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.
Jacobs A; Tjuvajev JG; Dubrovin M; Akhurst T; Balatoni J; Beattie B; Joshi R; Finn R; Larson SM; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO; Blasberg RG
Cancer Res; 2001 Apr; 61(7):2983-95. PubMed ID: 11306477
[TBL] [Abstract][Full Text] [Related]
12. Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors.
Snyder RO; Miao CH; Patijn GA; Spratt SK; Danos O; Nagy D; Gown AM; Winther B; Meuse L; Cohen LK; Thompson AR; Kay MA
Nat Genet; 1997 Jul; 16(3):270-6. PubMed ID: 9207793
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus vectors provide prolonged robust factor IX expression in mice.
Sclimenti CR; Neviaser AS; Baba EJ; Meuse L; Kay MA; Calos MP
Biotechnol Prog; 2003; 19(1):144-51. PubMed ID: 12573017
[TBL] [Abstract][Full Text] [Related]
14. Gene transfer into enteric neurons of the rat small intestine in organ culture using a replication defective recombinant herpes simplex virus type 1 (HSV1) vector, but not recombinant adenovirus vectors.
Brown OA; Santer RM; Shering AF; Larregina AT; Morelli AE; Southgate TD; Castro MG; Lowenstein PR
Gene Ther; 1997 Apr; 4(4):331-8. PubMed ID: 9176519
[TBL] [Abstract][Full Text] [Related]
15. Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters.
Ebara S; Shimura S; Nasu Y; Kaku H; Kumon H; Yang G; Wang J; Timme TL; Aguilar-Cordova E; Thompson TC
Prostate Cancer Prostatic Dis; 2002; 5(4):316-25. PubMed ID: 12627218
[TBL] [Abstract][Full Text] [Related]
16. Gene transfer into hepatocytes mediated by herpes simplex virus-Epstein-Barr virus hybrid amplicons.
Müller L; Saydam O; Saeki Y; Heid I; Fraefel C
J Virol Methods; 2005 Jan; 123(1):65-72. PubMed ID: 15582700
[TBL] [Abstract][Full Text] [Related]
17. Potential and limitations of a gamma 34.5 mutant of herpes simplex 1 as a gene therapy vector in the CNS.
McMenamin MM; Byrnes AP; Pike FG; Charlton HM; Coffin RS; Latchman DS; Wood MJ
Gene Ther; 1998 May; 5(5):594-604. PubMed ID: 9797863
[TBL] [Abstract][Full Text] [Related]
18. Herpes simplex virus-mediated gene delivery to the rodent visual system.
Spencer B; Agarwala S; Miskulin M; Smith M; Brandt CR
Invest Ophthalmol Vis Sci; 2000 May; 41(6):1392-401. PubMed ID: 10798655
[TBL] [Abstract][Full Text] [Related]
19. Long-term gene expression in the anterior horn motor neurons after intramuscular inoculation of a live herpes simplex virus vector.
Yamamura J; Kageyama S; Uwano T; Kurokawa M; Imakita M; Shiraki K
Gene Ther; 2000 Jun; 7(11):934-41. PubMed ID: 10849553
[TBL] [Abstract][Full Text] [Related]
20. Integration of active human beta-galactosidase gene (100 kb) into genome using HSV/AAV amplicon vector.
Oehmig A; Cortés ML; Perry KF; Sena-Esteves M; Fraefel C; Breakefield XO
Gene Ther; 2007 Jul; 14(14):1078-91. PubMed ID: 17460718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
